Next Generation Sequencing Market Worth US$30,424.3 Million by 2031: Visiongain Reports Ltd
Visiongain has published a new report entitled the Next Generation Sequencing Market 2021-2031. It includes profiles of Next Generation Sequencing Market By Technology (SBS, Ion Semiconductor Sequencing, Single Real Time Sequencing, Nanopore Sequencing & Other Sequencing Technology), By Products & Services (Instruments, Reagents & Consumables and Services), By Sequencing Tools (Illumina, Thermo Fischer, Oxford Nanopore, Pacific Biosciences and other platforms), By Reagents & Consumables, By Services (Sequencing Services & Bioinformatics), By Sequencing Services ( Whole Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Sequencing, ChIP sequencing, De Novo Sequencing, Methyl Sequencing and Others) By Applied Research ( Drug Discovery, Diagnostics, Personalized Medicine, Genetic Screening, Infectious Diseases, Agriculture & Animal Research & Others) By End Users (Biotech firms, Pharmaceutical companies, Hospital & Diagnostics centers and Others), By Leading National Market Analysis Plus Analysis of Leading NGS Market Players and COVID Recovery Scenarios.
Visiongain’s lead analyst says: ‘The Global Next Generation Sequencing Market was valued to be at US$ 9,368.3 million in 2021 and is expected to reach US$ 30,424.3 million by 2031 at a CAGR of 12.5% from 2021 – 2031. Rising preference for personalised medicine in developed as well as developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase NGS market concentration over the forecast period’.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/ngs-market-2021/#download_sampe_div
How has COVID-19 had a positive impact on the Next Generation Sequencing Market?
The primary application of NGS for infectious diseases has been useful to detect the virus without prior knowledge of the infectious agent. NGS workflows were deployed in various research labs and pathological laboratories to detect the SARS-CoV-2 virus. The NGS platforms and workflows are being used for surveillance, detection, tracking multiple variants and epidemiological studies. Various sequencing service providers introduced new RNA sequencing kits to support various studies that are being conducted with coronavirus-related which includes library preparation for whole genome sequencing, shot gun sequencing and targeted sequencing. For instance, Perkin Elmer introduced NEXTFLEX Rapid XP DNA-Seq kit which has been suitable for sequencing human DNA to analyse the clinical outcome in COVID-19. In March 2021, ThermoFischer introduced Ion AmpliSeq SARS-CoV-2 Research Panel to support COVID-19 epidemiological studies. Overall, COVID-19 triggered the demand for sequencing platforms and panels for research purposes consequently boosting the market growth.
How this Report Will Benefit you?
Our report captures in-depth analysis of NGS market within total 672 pages with 445 tables and 457 figures. The study helps all the stakeholders to discover and understand this lucrative NGS market with respect to financial results, trends, opportunities and identify business opportunities. This new study assists you in evaluating the overall market along with niche market segmentation analysis. Get financial analysis of sequencing market and its segments including market by technology, end users, applications, products & services. Huge opportunities are present in this fast-growing NGS market. See how to use the existing and upcoming opportunities in this market to gain a competitive edge in the near future. Moreover, the report will help you to improve your strategic decision making, allowing you to frame growth strategies, reinforce the analysis of other market players and finally maximize productivity for your company.
What are market drivers?
Growing incidence of cancer cases worldwide and the need to sequence the whole genome to understand the genetic vulnerability is driving the growth of NGS sequencing market. Moreover, precision medicine and predictive modelling are expected to drive the future diagnostics especially in cancer research. With growing demand for sequencing services, the sequencing platform manufacturers are introducing technologically advanced platforms which can provide highly accurate data with real time sequencing with reduced turnaround time.
Get Detailed TOC @ https://www.visiongain.com/report/ngs-market-2021/#download_sampe_div
Where are the market opportunities?
Application of precision medicine and biomarker discovery to treat cancer patients with a typical trait which needs to be studied through comprehensive genome profiling and drug development. NGS technology has become inevitable. In 2019, ThermoFischer launched Oncomine Precision Assay which runs on Ion Torrent Genexus System which is a completely automated NGS platform which delivers comprehensive genomic profiling information within 24 hours. In addition, evolving IT infrastructure along integration of NGS platforms with cloud based technology to generate, analyse genome data has opened a new avenue for cloud based companies providing data management solutions to genome sequencing firms.
Competitive Landscape
The major players in NGS platforms market include Illumina (US), ThermoFischer (US), Pacific Biosciences (US), Oxford Nanopore (UK) and BGI Genomics. The other companies such as Perkin Elmer, Qiagen, Genewiz, BGI are sequencing service providers. Companies are stay abreast in this highly competitive market through M&A and collaborations. For Instance, in September 2020, Illumina announced the acquisition of GRAIL to further fortify its market presence in Oncology sector. In January 2021, Illumina announced its oncology partnership with Bristol Myers Squibb, Kura oncology, Myriad Genetics and Merck. This partnership aims to provide comprehensive genomic profiling through use of its TruSight oncology pre cancer assay which as has been designed 523 known and other emerging tumor biomarkers. The TruSight is currently in review with regulatory authorities.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Global NGS Market, And leading companies. You will find data, trends and predictions.
Find more research reports on the Pharmaceutical Industry click on:
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: dev.visavadia@visiongain.com
About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.
Contact:
Dev Visavadia
PR at Visiongain Reports Limited
Tel: + 44 0207 336 6100
Email: dev.visavadia@visiongain.com
